EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling

Lei Wang, Weijun Yi, Li Ma, Emily Lecea, Lori A Hazlehurst iD, Donald A Adjeroh, Gangqing Hu iD

Cancers · 26.10.2023 · 15 (21) · 5148

DOI: 10.3390/cancers15215148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 26.10.2023. Verfasst von Lei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology & Cell Biology, West Virginia University, Morgantown, WV 26505, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH NIGMS, NSF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone marrow mesenchymal stem cells (BM MSCs) play a tumor-supportive role in promoting drug resistance and disease relapse in multiple myeloma (MM). Recent studies have discovered a sub-population of MSCs, known as inflammatory MSCs (iMSCs), exclusive to the MM BM microenvironment and implicated in drug resistance. Through a sophisticated analysis of public expression data from unexpanded BM MSCs, we uncovered a positive association between iMSC signature expression and minimal residual disease. While in vitro expansion generally results in the loss of the iMSC signature, our meta-analysis of additional public expression data demonstrated that cytokine stimulation, including IL1-β and TNF-α, as well as immune cells such as neutrophils, macrophages, and MM cells, can reactivate the signature expression of iMSCs to varying extents. These findings underscore the importance and potential utility of cytokine stimulation in mimicking the gene expression signature of early passage of iMSCs for functional characterizations of their tumor-supportive roles in MM.

Schlagwörter

Stichwörter der Autor:innen

IL-1βbone marrowinflammatory MSCsmultiple myelomatranscriptional signature

Autor:innen und Institutionen

  • Department of Microbiology, Immunology & Cell Biology, West Virginia University, Morgantown, WV 26505, USA.
  • Lane Department of Computer Science & Electrical Engineering, West Virginia University, Morgantown, WV 26506, USA.
  • WVU Cancer Institute, West Virginia University, Morgantown, WV 26506, USA.
  • Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morganton, WV 26506, USA.

ORCID-Profile: Lori A Hazlehurst, Gangqing Hu

Förderung

  • NIGMS NIH HHS
  • NIH NIGMS
  • NSF

Zitieren

APA

Wang, L., Yi, W., Ma, L., Lecea, E., Hazlehurst, L. A., Adjeroh, D. A., & Hu, G. (2023). Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling. Cancers, 15(21), 5148. https://doi.org/10.3390/cancers15215148

Vancouver

Wang L, Yi W, Ma L, Lecea E, Hazlehurst LA, Adjeroh DA, et al. Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling. Cancers. 2023;15(21):5148. doi:10.3390/cancers15215148

BibTeX
@article{Wang2023,
  author = {Wang, Lei and Yi, Weijun and Ma, Li and Lecea, Emily and Hazlehurst, Lori A and Adjeroh, Donald A and Hu, Gangqing},
  title = {Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {21},
  pages = {5148},
  doi = {10.3390/cancers15215148}
}
Kostenlos starten →